Skip to main content
PALI logo

Palisade Bio, Inc.

PALINASDAQHealthcareBiotechnology

$1.54Today:- (-)1Y −10.98%

As of Oct 15, 2026 close

Market cap
$325.53M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.32$2.86
Volume (live)
-
Avg. volume (3M)
3.30M

Palisade Bio, Inc. (PALI) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Palisade Bio, Inc. stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Buy
Based on 6 unique analysts
Medium Confidence∞:1 Buy/Sell

Average Price Target

$10.17
+560.39% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest PALI Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Unknown Analyst
Raymond James
BuyInitiates
$6.00
Yasmeen Rahimi
Piper Sandler
BuyMaintains
$25.00
Mitchell Kapoor
HC Wainwright
BuyReiterates
$7.00
Naz Rahman
Maxim
BuyReiterates
$8.00
Unknown Analyst
B Riley
BuyInitiates
$7.00
Leland Gershell
Oppenheimer
BuyReiterates
$8.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 8, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for PALI?

The analyst consensus rating for PALI is Buy, based on the latest ratings from 6 analysts over the last 90 days.

What is the average price target for PALI?

The average 12-month price target for PALI is $10.17, representing an upside of 560.4% from the Oct 15, 2026 close of $1.54.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.